WFSBP 2019 Final Program

45 Wednesday, 5 June 2019 / Scientific Program WFSBP 2019 WED 005 Machine Learning Classification of Bipolar Disorder using Multimodal Neurocognitive Measures Rashmin Achalia, India A. Sinha, G. Achalia, N. Rao PL-03 PLENARY SESSION 10:00–11:00 Ballroom B/C Immunometabolic depression: ready for personalized medicine Chair: Michael Berk, Australia Co-Chair: Glenda MacQueen, Canada Speaker: Brenda Penninx, The Netherlands D-03 DEBATE 11:30–13:00 Ballroom B/C Early intervention for Psychosis: Is it worth the investment? Chair: Matcheri Keshavan, USA Proponent: Ashok Malla, Canada Opponent: David Castle, Australia T57: STIMULATION METHODS (E.G. ECT, TMS, VNS, DBS) S-48 SYMPOSIUM 11:30–13:00 Ballroom A Novel strategies to leverage non-invasive neurostimulation for depression Chair: Alexander McGirr, Canada Co-Chair: Chris Baeken, Belgium 001 The role of neurocognition in optimising outcomes from non-invasive brain stimulation Donel Martin, Australia 002 Time to accelerate non-invasive neurostimulation in major depressive disorder?: Insights from brain imaging Chris Baeken, Belgium 003 Enhancing plasticity as a means of augmenting repetitive transcranial magnetic stimulation Alexander McGirr, Canada 004 Resting-state biomarkers and antidepressant ef- fects of targeted non-invasive neurostimulation Conor Liston, USA T7: BIPOLAR DISORDERS: BASIC/CLINICAL S-49 SYMPOSIUM 11:30–13:00 East Meeting Room 8/15 Novel approaches to the neurobiology, classification, course and treatment of youth Bipolar Disorder (BD) Chair: Benjamin Goldstein, Canada Co-Chair: Eric Youngstrom, USA 001 Evidence-based assessment from simple clinical judgments to statistical learning: Comparing methods using pediatric Bipolar Disorder as a diagnostic chal- lenge Eric Youngstrom, USA 002 Prodromal states in Bipolar Disorder Boris Birmaher, USA 003 Differential effect of lithium and quetiapine on neural response during sustained attention among manic youth L. Rodrigo Patino Duran, USA 004 Neuroimaging phenotypes of anomalous microvas- cular function in youth bipolar disorder Benjamin Goldstein, Canada T1: ADDICTIVE DISORDERS S-50 SYMPOSIUM 11:30–13:00 East Meeting Room 13 Bridging the gap: A global mental health perspective on substance use treatment and research Chair: Michael Krausz, Canada Co-Chair: Daniel Vigo, Canada 001 Global collaboration addressing opiate addiction based on traditional medicine Michael Krausz, Canada 002 Behavioral pharmacology and traditional medi- cine to develop innovative treatments for substance use disorders Anthony Phillips, Canada 003 Integrating biological and psychosocial approaches to substance use disorders from a global health systems perspective Daniel Vigo, Canada 004 The use of opium tincture for substitution treat- ment in Asia?: An RCT comparing it to metha-done Mohammadali Nikoo, Canada